AFT Pharmaceuticals - Pascomer falls short of FDA mandated threshold
AFT Pharmaceuticals announced that its Pascomer Phase II clinical trial has failed to meet its primary endpoint of a two-point improvement on the Investigator's Global Assessment (IGA) scale. Pascomer
Kostenloser Wertpapierhandel Timber Pharmaceuticals Pascomer Phase Global Assessment Facial Angiofibroma Severity Index
Source: finanznachrichten.de